Polymerase chain reaction (PCR)-based construction of a competitor target for quantitative reverse transcriptase PCR measurement of cytochrome P450 1A1 mRNA.
Frötschl
R
R
Institute of Clinical Pharmacology, University Hospital Charité, Humboldt University of Berlin, Germany.
Kleeberg
U
U
Hildebrandt
A G
AG
Roots
I
I
Brockmöller
J
J
D001483:Base Sequence; D002623:Chemistry Techniques, Analytical / Q000379:methods / Q000592:standards; D019363:Cytochrome P-450 CYP1A1 / Q000235:genetics*; D017931:DNA Primers / Q000235:genetics; D004294:Domperidone / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D009853:Omeprazole / Q000494:pharmacology; D016133:Polymerase Chain Reaction / Q000379:methods* / Q000592:standards; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics* / Q000592:standards; D012015:Reference Standards
D017931:DNA Primers; D012333:RNA, Messenger; D004294:Domperidone; D019363:Cytochrome P-450 CYP1A1; D009853:Omeprazole